ImageneBio, Inc. Other Non-Current Liabilities
ImageneBio, Inc. (IMA) had Other Non-Current Liabilities of $838.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-08-05
- 2026-06-30: Other Liabilities, Noncurrent $838.00K.
- 2026-03-31: Other Liabilities, Noncurrent $881.00K.
- 2025-12-31: Other Liabilities, Noncurrent $870.00K.
- 2025-09-30: Other Liabilities, Noncurrent $1.11M.
| Period end | Other Liabilities, Noncurrent | Other Liabilities, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $838.00K 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $881.00K 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $870.00K 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $1.11M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $1.09M 10-Q · filed 2025-07-24 | |
| 2025-03-31 | $1.08M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $0.00 10-K · filed 2026-03-10 | $1.06M 10-Q · filed 2025-05-08 |
| 2024-09-30 | $1.04M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $1.03M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $964.00K 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $950.00K 10-Q · filed 2024-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |